Article
Mutational analysis of PDGFR-RAS/MAPK pathway activation in childhood medulloblastoma.
European journal of cancer (Oxford, England : 1990) - 1 Mar 2006
Gilbertson Richard J, Langdon Jaqueline A, Hollander Andrew, Hernan Roberto, Hogg Twala L, Gajjar Amar, Fuller Christine, Clifford Steven C
Abstract excerpt
Aberrant signalling via platelet derived growth factor receptors (PDGFRs) and the RAS/MAPK pathway has been implicated in the development of medulloblastoma, the most common malignant brain tumour in childhood. To determine whether genetic mechanisms play a role in the activation of PDGFR-RAS/MAPK signalling in medulloblastoma, we performed a direct sequence analysis of the established mutational "hotspots" of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
